Nobiletin and its derivatives overcome multidrug resistance (MDR) in cancer: total synthesis and discovery of potent MDR reversal agents.
Acta Pharm Sin B
; 10(2): 327-343, 2020 Feb.
Article
em En
| MEDLINE
| ID: mdl-32082977
Ac2O, acetic anhydride; AcOH, acetic acid; AcONa, sodium acetate; BF3·Et2O, boron trifluoride diethyl etherate; Cancer multidrug resistance; DCE, dichloroethane; DCM, dichloromethane; DMF, N,N-dimethylformamide; DMSO, dimethyl sulfoxide; DOX, doxorubicin; Et3N, triethylamine; Flutax-2, a fluorescent taxol derivative; MDR, multidrug resistance; Mechanism; NIS, N-iodosuccinimide; NOB, nobiletin; Nobiletin; P-gp inhibition; P-gp, P-glycoprotein; PI, propidium iodide; PTX, paclitaxel; QND, quinidine; Reversal agents; Rho123, rhodamine 123; SRB, sulforhodamine B; Solubility; TCA, trichloroacetic acid; THF, tetrahydrofuran; TLC, thin-layer chromatography; Total synthesis; Ver, verapamil; t-BuOK, potassium tert-butylate
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Revista:
Acta Pharm Sin B
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
China